Roche Clinical Trials

Clinical trials sponsored by Roche — phases, conditions and reported results. Data from ClinicalTrials.gov.

• A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Ri
  Phase 3 · Non-Hodgkin Lymphoma · Active, not recruiting · Mar 6, 2026
• Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patien
  Phase 1/2 · Urothelial Carcinoma · Terminated · Aug 3, 2026
• A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable
  Phase 1/2 · Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma · Terminated · Aug 3, 2026
• Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants
  Phase 3 · Thyroid Eye Disease · Completed · Jul 31, 2026
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults W
  Phase 3 · Multiple Sclerosis · Active, not recruiting · Feb 17, 2026
• Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Che
  Phase 3 · Non-Small Cell Lung Cancer · Active, not recruiting · Mar 30, 2025
• Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
  Phase 1/2 · Age-Related Macular Degeneration · Active, not recruiting · Mar 6, 2023
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults W
  Phase 3 · Multiple Sclerosis · Active, not recruiting · Jul 24, 2026
• Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prio
  Phase 2 · Metastatic HER2-Positive Breast Cancer · Completed · Jul 24, 2026
• BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma
  Phase 3 · Pleural Mesothelioma Malignant Advanced · Completed · May 14, 2026
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV
  Phase 3 · Lupus Nephritis · Active, not recruiting · Nov 6, 2025
• ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer
  Phase 2 · Non-small Cell Lung Cancer · Terminated · Mar 26, 2025
• A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in P
  Phase 2 · Non-small Cell Lung Cancer · Completed · Nov 19, 2025
• A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
  Phase 3 · Asthma · Completed · Jul 17, 2026
• A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Coliti
  Phase 2 · Moderate to Severe Ulcerative Colitis · Completed · Dec 16, 2025

Trials by company

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

All trials